ExLibris header image
SFX Logo
Title: Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Erbayraktar, S yr:2003


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Leist, M. "Derivatives of erythropoietin that are tissue protective but not erythropoietic." Science 305.5681 (2004): 239-242. Link to SFX for this item
2. Egrie, Joan C C. "Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin." Experimental hematology 31.4 (2003): 290-9. Link to SFX for this item
3. Sharples, Edward J J. "Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion." Journal of the American Society of Nephrology 15.8 (2004): 2115-24. Link to SFX for this item
4. Park, Mi Hee H. "ERK-mediated production of neurotrophic factors by astrocytes promotes neuronal stem cell differentiation by erythropoietin." Biochemical and biophysical research communications 339.4 (2005): 1021-8. Link to SFX for this item
5. Villa, P. "Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis." The Journal of experimental medicine 198.6 (2003): 971-5. Link to Full Text for this item Link to SFX for this item
6. Mennini, T. "Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo." Molecular medicine 12.7-8 (2006): 153-160. Link to Full Text for this item Link to SFX for this item
7. Sakanaka, M. "In vivo evidence that erythropoietin protects neurons from ischemic damage." Proceedings of the National Academy of Sciences of the United States of America 95.8 (1998): 4635-4640. Link to Full Text for this item Link to SFX for this item
8. Elliott, S. "Control of rHuEPO biological activity: the role of carbohydrate." Experimental hematology 32.12 (2005): 1146-55. Link to SFX for this item
9. Bianchi, R. "Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity." Clinical cancer research 12.8 (2006): 2607-12. Link to SFX for this item
10. Calvillo, L. "Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling." Proceedings of the National Academy of Sciences of the United States of America 100.8 (2003): 4802-6. Link to Full Text for this item Link to SFX for this item
11. Vesey, David A A. "Erythropoietin protects against ischaemic acute renal injury." Nephrology, dialysis, transplantation 19.2 (2004): 348-55. Link to SFX for this item
12. Woolf, Clifford J. "The neuropathic pain triad: neurons, immune cells and glia." Nature neuroscience 10.11 (2007): 1361-8. Link to Full Text for this item Link to SFX for this item
13. Brines, M. "Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor." Proceedings of the National Academy of Sciences of the United States of America 101.41 (2004): 14907-12. Link to Full Text for this item Link to SFX for this item
14. Minnerup, J. "Neuroprotection for stroke: Current status and future perspectives." International journal of molecular sciences 13.9 (2012): 11753-11772. Link to Full Text for this item Link to SFX for this item
15. Agoram, B. "Population pharmacokinetics of darbepoetin alfa in healthy subjects." British journal of clinical pharmacology 63.1 (2006): 41-52. Link to Full Text for this item Link to SFX for this item
16. Kohler, M. "Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels." International journal of sports medicine 29.1 (2007): 1-6. Link to SFX for this item
17. Crigler, L. "Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis." Experimental neurology 198.1 (2006): 54-64. Link to SFX for this item
18. Erbayraktar, S. "Carbamylated erythropoietin reduces radiosurgically-induced brain injury." Molecular medicine 12.4-6 (2006): 74-80. Link to Full Text for this item Link to SFX for this item
19. Ehrenreich, H. "Erythropoietin therapy for acute stroke is both safe and beneficial." Molecular medicine 8.8 (2002): 495-505. Link to Full Text for this item Link to SFX for this item
20. Kilic, E. "Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways." The FASEB journal 19.14 (2006): 2026-8. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced